WSJ
10 Jul 2026, 06:45 UTC · 1h ago
Apollo to Buy $3.4 Billion Stake in Bayer Contraceptives Business
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
WSJ
10 Jul 2026, 06:45 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
1 claim · each scored for market impact
An asset-management firm is acquiring a minority stake in Bayer's long-acting reversible contraceptives business. — The transaction indicates external valuation and capital infusion for a specific Bayer business unit, though the minority nature limits overall corporate impact.
+0.30Which stocks this story touches
The company is successfully monetizing a business unit by selling a minority stake.
Continue reading
6 related stories
Top 1 mover · tap to explore
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
GlobeNewsWire
8h ago
